Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jikui Guan

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Elife|September 30, 2015
FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinaseJikui Guan, Ganesh Umapathy, Yasuo Yamazaki, et al.
NPJ Precision Oncology|February 26, 2026
Novel activating SNRNP70-ALK fusion in congenital infant-type hemispheric glioma displays clinical response to lorlatinib: a case-reportCecilia Arthur, Kleopatra Georgantzi, Teresita Díaz de Ståhl, et al.
Cell Reports|July 14, 2021
Extracellular domain shedding of the ALK receptor mediates neuroblastoma cell migrationHao Huang, Alexander Gont, Lynn Kee, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 2023
ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibitionMarcus Borenäs, Ganesh Umapathy, Dan E Lind, et al.
The EMBO Journal|January 7, 2021
ALK ligand ALKAL2 potentiates MYCN-driven neuroblastoma in the absence of ALK mutationMarcus Borenäs, Ganesh Umapathy, Wei-Yun Lai, et al.
Cold Spring Harbor Molecular Case Studies|June 17, 2018
Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinibJikui Guan, Susanne Fransson, Joachim Tetteh Siaw, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Elife|September 30, 2015
FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinaseJikui Guan, Ganesh Umapathy, Yasuo Yamazaki, et al.
NPJ Precision Oncology|February 26, 2026
Novel activating SNRNP70-ALK fusion in congenital infant-type hemispheric glioma displays clinical response to lorlatinib: a case-reportCecilia Arthur, Kleopatra Georgantzi, Teresita Díaz de Ståhl, et al.
Cell Reports|July 14, 2021
Extracellular domain shedding of the ALK receptor mediates neuroblastoma cell migrationHao Huang, Alexander Gont, Lynn Kee, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 2023
ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibitionMarcus Borenäs, Ganesh Umapathy, Dan E Lind, et al.
The EMBO Journal|January 7, 2021
ALK ligand ALKAL2 potentiates MYCN-driven neuroblastoma in the absence of ALK mutationMarcus Borenäs, Ganesh Umapathy, Wei-Yun Lai, et al.
Cold Spring Harbor Molecular Case Studies|June 17, 2018
Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinibJikui Guan, Susanne Fransson, Joachim Tetteh Siaw, et al.
Pageof 3